US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Research & Development Market Research Reports & Industry Analysis

The term research and development (R&D) refers to work that is done in order to better understand the nature, function or understanding of a topic or product in order to gain knowledge and find new applications for existing products or to develop new and innovative products. This is usually performed by corporations, government agencies, and research or academic institutions.

New product design and development is essential for the survival and growth of many companies, as markets and consumers’ tastes are fickle and the competition can be fierce. In order to stay relevant in a fast changing marketplace, firms have to constantly revise and expand their range of product offerings. Therefore, research and development is of great economic importance as companies fight to maintain their market share, though it may mean forgoing current profits in favor of potential future performance and returns.

Research and development is most often associated with the technology industry, as well as with science and in particular with healthcare and the development of new pharmaceuticals, diagnostics or medical devices that are safe and effective. For instance, drug makers must constantly search for the next big blockbuster drug, since the products they currently have on the market will eventually lose their patent protection and be vulnerable to generic competition. So they spend huge amounts of money on R&D because without a promising drug pipeline their revenue stream will ultimately dry up.

RSS Feeds

Research & Development Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Melanoma Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Melanoma Partnering 2009-2014 provides understanding and access to the melanoma partnering deals and agreements entered into by the worlds ...  |  read more...
USD 995
Angioedema Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... by value Deals listed by company A-Z, industry sector, stage of development, technology type Angioedema Partnering 2009-2014 provides understanding and access to the angioedema partnering deals and agreements entered into by the worlds leading healthcare ...  |  read more...
USD 995
Viral Partnering Terms and Agreements
11/1/2014 | published by: Current Partnering
... report provides a detailed understanding and analysis of how and why companies enter viral partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right ...  |  read more...
USD 995
Parasitic Disease Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors parasitic technology. These deals tend to be multicomponent, starting with ...  |  read more...
USD 695
Drug Addiction Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... deals Top drugs deal addiction by value Deals listed by company A-Z, industry sector, stage of development, technology type Drug Addiction Partnering 2009-2014 provides understanding and access to the drug addiction partnering deals and agreements ...  |  read more...
USD 695
Smoking Cessation Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... Top smoking deals by value Deals listed by company A-Z, industry sector, stage of development, technology type Smoking Cessation Partnering 2009-2012 provides understanding and access to the smoking partnering deals and agreements entered into by ...  |  read more...
USD 695
Epilepsy Drugs Market in India - Sectoral Capsule
11/1/2014 | published by: Gyan Research and Analytics Pvt. Ltd.
... 2013 was USD 4.28 billion. With a Compound Annual Growth Rate (CAGR) of 2 percent through 2009-2018, it is expected to clock a turnover of USD 4.73 billion in 2018. The epilepsy drug market accrued ...  |  read more...
USD 250
Bioscience (UK) - Industry Report
11/5/2014 | published by: Plimsoll Publishing Ltd.
... – analysing the 240 largest Bioscience (UK) companies. The Bioscience (UK) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the first section thoroughly scrutinises ...  |  read more...
USD 560
Clinical Research (UK) - Industry Report
11/5/2014 | published by: Plimsoll Publishing Ltd.
... graphical analysis – analysing the 110 largest Clinical Research (UK) companies. The Clinical Research (UK) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the ...  |  read more...
USD 560
Medical & Scientific Research (European) - Industry Report
11/5/2014 | published by: Plimsoll Publishing Ltd.
... written and graphical analysis – analysing the 500 largest Medical & Scientific Research (European) companies. The Medical & Scientific Research (European) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their ...  |  read more...
USD 1,280
Global Prostate Cancer Drugs Market 2014-2018
11/5/2014 | published by: TechNavio - Infiniti Research Ltd.
... make fluid for semen. The risk of developing prostate cancer is age dependent. Prostate cancer affects mostly men over the age of 65 and rarely occurs in men younger than 40 years of age. TechNavio's ...  |  read more...
USD 2,500
Prostate Cancer Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Prostate Cancer in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 670
HIV Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing ...  |  read more...
USD 670
Multiple Sclerosis Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Multiple Sclerosis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 670
Parkinson's Disease Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Parkinson's Disease in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 670
Acute Myeloid Leukemia Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... emerging therapies for Acute Myeloid Leukemia in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating ...  |  read more...
USD 670
Depression Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing ...  |  read more...
USD 670
Schizophrenia Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing ...  |  read more...
USD 670
Glioblastoma Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing ...  |  read more...
USD 670
Osteoarthritis Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing ...  |  read more...
USD 670
Congestive Heart Failure Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... emerging therapies for Congestive Heart Failure in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating ...  |  read more...
USD 670
Influenza Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing ...  |  read more...
USD 670
Osteoporosis Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing ...  |  read more...
USD 670
Chronic Pain Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Chronic Pain in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 670
Epilepsy Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing ...  |  read more...
USD 670
< prev 1    3  4  5  6  7  8  9  10